sodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide

C45H56BBr3N9NaO10S3 — CID 157360221

IUPACsodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
SMILESBrCc1cncc(Br)c1.CC1(C)OB(c2cnc3c(c2)CCCN3C(N)=O)OC1(C)C.CS(=O)(=O)Cc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1.CS(=O)(=O)Cc1cncc(Br)c1.CS(=O)[O-].[Na+]
InChIInChI=1S/C16H18N4O3S.C15H22BN3O3.C7H8BrNO2S.C6H5Br2N.CH4O2S.Na/c1-24(22,23)10-11-5-13(8-18-7-11)14-6-12-3-2-4-20(16(17)21)15(12)19-9-14;1-14(2)15(3,4)22-16(21-14)11-8-10-6-5-7-19(13(17)20)12(10)18-9-11;1-12(10,11)5-6-2-7(8)4-9-3-6;7-2-5-1-6(8)4-9-3-5;1-4(2)3;/h5-9H,2-4,10H2,1H3,(H2,17,21);8-9H,5-7H2,1-4H3,(H2,17,20);2-4H,5H2,1H3;1,3-4H,2H2;1H3,(H,2,3);/q;;;;;+1/p-1
InChIKeyBAJCGBWLJZJQPR-UHFFFAOYSA-M
MW1252.71 g/mol
LogP3.36
Rot. Bonds7

About sodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide

sodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide (PubChem CID 157360221) has the molecular formula C45H56BBr3N9NaO10S3 and a molecular weight of 1252.71 g/mol. Its IUPAC name is sodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide.

Molecular Properties

Compound Namesodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
PubChem CID157360221
Molecular FormulaC45H56BBr3N9NaO10S3
Molecular Weight1252.71 g/mol
Exact Mass1249.09
IUPAC Namesodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
SMILESBrCc1cncc(Br)c1.CC1(C)OB(c2cnc3c(c2)CCCN3C(N)=O)OC1(C)C.CS(=O)(=O)Cc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1.CS(=O)(=O)Cc1cncc(Br)c1.CS(=O)[O-].[Na+]
InChIInChI=1S/C16H18N4O3S.C15H22BN3O3.C7H8BrNO2S.C6H5Br2N.CH4O2S.Na/c1-24(22,23)10-11-5-13(8-18-7-11)14-6-12-3-2-4-20(16(17)21)15(12)19-9-14;1-14(2)15(3,4)22-16(21-14)11-8-10-6-5-7-19(13(17)20)12(10)18-9-11;1-12(10,11)5-6-2-7(8)4-9-3-6;7-2-5-1-6(8)4-9-3-5;1-4(2)3;/h5-9H,2-4,10H2,1H3,(H2,17,21);8-9H,5-7H2,1-4H3,(H2,17,20);2-4H,5H2,1H3;1,3-4H,2H2;1H3,(H,2,3);/q;;;;;+1/p-1
InChIKeyBAJCGBWLJZJQPR-UHFFFAOYSA-M
XLogP3.36
TPSA283.98 Ų
H-Bond Donors2
H-Bond Acceptors15
Rotatable Bonds7
Heavy Atoms72
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001252.71
LogP ≤ 53.36
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'sulfinic_acid', 'substructure': 'N/A'}

Analyze sodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of sodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide?
The IUPAC name of sodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide (CID 157360221) is sodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide.
What is the SMILES notation for sodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide?
The canonical SMILES for sodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide is BrCc1cncc(Br)c1.CC1(C)OB(c2cnc3c(c2)CCCN3C(N)=O)OC1(C)C.CS(=O)(=O)Cc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1.CS(=O)(=O)Cc1cncc(Br)c1.CS(=O)[O-].[Na+].
What is the InChIKey of sodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide?
The InChIKey is BAJCGBWLJZJQPR-UHFFFAOYSA-M. The full InChI is InChI=1S/C16H18N4O3S.C15H22BN3O3.C7H8BrNO2S.C6H5Br2N.CH4O2S.Na/c1-24(22,23)10-11-5-13(8-18-7-11)14-6-12-3-2-4-20(16(17)21)15(12)19-9-14;1-14(2)15(3,4)22-16(21-14)11-8-10-6-5-7-19(13(17)20)12(10)18-9-11;1-12(10,11)5-6-2-7(8)4-9-3-6;7-2-5-1-6(8)4-9-3-5;1-4(2)3;/h5-9H,2-4,10H2,1H3,(H2,17,21);8-9H,5-7H2,1-4H3,(H2,17,20);2-4H,5H2,1H3;1,3-4H,2H2;1H3,(H,2,3);/q;;;;;+1/p-1.
What are the key properties of sodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide?
sodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide has a molecular weight of 1252.71 g/mol, XLogP of 3.36, 7 rotatable bonds, 2 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for sodium;3-bromo-5-(bromomethyl)pyridine;3-bromo-5-(methylsulfonylmethyl)pyridine;methanesulfinate;6-[5-(methylsulfonylmethyl)-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide is sourced from PubChem (CID 157360221), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).